Grifols SA (GRFS)
9.205
-0.02
(-0.16%)
USD |
NASDAQ |
Feb 11, 16:00
9.205
0.00 (0.00%)
After-Hours: 17:51
Grifols Shareholders Equity (Quarterly) : 6.085B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | 22.69M |
| Pharma Mar SA | 232.07M |
| Autolus Therapeutics Plc | 265.45M |
| Oryzon Genomics SA | 124.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.33B |
| Total Liabilities (Quarterly) | 14.46B |
| Debt to Equity Ratio | 1.871 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | 0.06% |